Life Science Insights 360 Podcasts

About Life Science Insights 360 Podcasts

Welcome to Life Science Insights360, your go-to source for deep conversations with the innovators shaping the future of healthcare, biotech, and life sciences. Hosted by Senthil Karunanith, each episode dives into cutting-edge topics—from translational omics and therapeutic breakthroughs to strategic data insights, quality management, and real-world challenges in pharma, medtech, and diagnostics . Expect dynamic interviews with industry leaders—CEOs, scientists, strategists—who share real-world case studies and forward-thinking visions.

Publisher

Life Science Insights360

Category

science

Language

en

Explicit

No

First episode

5 May 2025

Latest episode

17 Sept 2026

Latest episodes

35 episodes in the feed.

1. 

   17 Sept 2026

   E35 - Building the Future of Cell Therapy |Dr. Ron Cohen CEO of Oryon Cell Therapies

   We are honored to welcome Dr. Ron Cohen, CEO of Oryon Cell Therapies and a distinguished leader in the biotechnology industry.With more than three decades of experience building innovative biotech companies, raising significant capital, and advancing therapies for patients, Dr. Cohen has made a lasting impact on the life sciences community.At Oryon Cell Therapies, he is leading the development of next-generation cell therapies with a focus on neurodegenerative diseases and the potential of regenerative medicine to address some of the most challenging conditions in healthcare.In this conversation, we explore his entrepreneurial journey, leadership lessons, biotech financing, the rapidly evolving field of cell therapy, and his vision for the future of regenerative medicine.Key Topics Discussed#Dr. Ron Cohen’s three-decade journey in biotechnology and entrepreneurship#What inspired him to pursue biotech rather than a traditional medical career#Lessons learned from setbacks and challenges throughout his entrepreneurial journey#His leadership philosophy and how it has evolved over the past 30 years#Why he joined Oryon Cell Therapies and his vision for its next chapter#The evolution of cell therapy and regenerative medicine#Scientific opportunities that were not possible just five years ago#What differentiates Oryon Cell Therapies in the regenerative medicine landscape#The potential of cell therapy in treating neurodegenerative diseases#Therapeutic areas where cell therapy could deliver major breakthroughs#Raising more than $1.1 billion in capital throughout his career#Advice for first-time biotech founders seeking investment#What investors look for in successful biotech CEOs beyond great science#Building resilient organizations and high-performance biotech teams#Creating a culture that thrives through both successes and setbacksEpisode Highlights#The Future of Cell Therapy — Exploring how advances in cell biology and regenerative medicine are opening new possibilities for treating complex diseases.#Neurodegenerative Diseases — Understanding the potential of next-generation cell therapies to address some of the most challenging neurological conditions.#Biotech Entrepreneurship — Dr. Cohen shares lessons from more than 30 years of building companies and advancing innovative therapies.#Raising Capital — Insights into biotech fundraising, investor expectations, and what founders need to demonstrate beyond compelling science.#Leadership & Culture — Practical lessons on building teams, navigating setbacks, and creating organizations capable of sustained innovation.#The Future of Biotechnology — Dr. Cohen shares his perspective on where cell therapy and regenerative medicine are heading and the opportunities that lie ahead.Whether you’re a biotech entrepreneur, scientist, physician, investor, pharmaceutical executive, cell therapy researcher, or healthcare innovator, this episode provides valuable perspectives on the science, business, and leadership shaping the next generation of biotechnology.Subscribe for conversations with leaders across biotechnology, pharmaceuticals, healthcare, clinical research, AI, cell therapy, and life sciences.#LifeScienceInsights360 #RonCohen #OryonCellTherapies #CellTherapy #Biotechnology #RegenerativeMedicine #NeurodegenerativeDiseases #Biotech #DrugDevelopment #LifeSciences #HealthcareInnovation #BiotechEntrepreneur #BiotechLeadership #VentureCapital #ClinicalResearch

2. 

   14 Sept 2026

   E34 - The Science of One Health | Dr. Alex Shneider, CEO CureLab Oncology and CureLab Veterinary

   Dr. Shneider is pioneering innovative approaches to cancer treatment through Elenagen, a novel biological therapeutic being investigated for difficult-to-treat cancers. His unique approach connects human and veterinary oncology, advancing the One Health vision while challenging conventional approaches to biotechnology development.In this conversation, we explore Dr. Shneider’s journey in biotechnology and oncology, the science behind Elenagen, clinical development, cancer immunology, and the potential of combining human and veterinary research to accelerate therapeutic innovation.Key Topics Discussed#Dr. Alexander Shneider’s journey into biotechnology and oncology#The mission and vision behind CureLab Oncology#Understanding Elenagen and its novel approach to cancer treatment#How Elenagen interacts with the immune system#The role of chronic inflammation in cancer#Clinical development and research in difficult-to-treat cancers#Insights into platinum-resistant ovarian cancer#Combining innovative therapies with chemotherapy and immunotherapy#The philosophy of going “from the drug to the mechanism”#Challenging traditional biotechnology development models#The One Health connection between human and veterinary oncology#Cancer research in dogs and its potential relevance to human medicine#How veterinary medicine can contribute to human drug development#Capital-efficient biotech development and innovation#Leadership lessons from building CureLab#The future of cancer treatment, biotechnology, and precision medicineEpisode Highlights#A deep dive into the science and potential of Elenagen#Dr. Shneider’s perspective on the relationship between cancer, inflammation, and immunity#How human and veterinary oncology can work together under the One Health approach#Insights into innovative and capital-efficient biotech development#Perspectives on the future of cancer therapeutics and biotechnology innovation#Leadership and entrepreneurship lessons from a scientist building companies around novel cancer therapiesWhether you're a biotechnology professional, oncologist, researcher, physician, investor, entrepreneur, or healthcare innovator, this episode offers valuable insights into the science, strategy, and innovation shaping the future of cancer treatment.#LifeScienceInsights360 #AlexanderShneider #CureLabOncology #Elenagen #Oncology #CancerResearch #CancerTreatment #Biotechnology #PrecisionMedicine #OneHealth #VeterinaryOncology #DrugDevelopment #Pharma #LifeSciences #HealthcareInnovation

3. 

   3 Sept 2026

   E32

   e32

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

1 ratings

Contact Life Science Insights 360 Podcasts

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.